Young Innovations, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Young Innovations, Inc. - overview
Established
1900
Location
Algonquin, IL, US
Primary Industry
Medical Devices & Equipment
About
Young Innovations, Inc. is a US-based company specializing in the manufacturing and distribution of dental products that enhance patient care and improve dental practices. Founded in 1900 in Algonquin, US, Young Innovations, Inc. operates in the dental products sector, focusing on manufacturing solutions for various dental practices.
The company underwent a significant ownership change when The Jordan Company acquired a majority stake in November 2017. The firm has successfully raised USD 314. 00 mn through funding rounds, with Linden Capital Partners leading the most recent round categorized as Public to Private. Dave Sproat is the current CEO.
Young Innovations specializes in the manufacturing and distribution of a comprehensive range of dental products aimed at enhancing patient care and improving dental practices. Their core product offerings include solutions for endodontics, restorative dentistry, infection control, preventive care, and orthodontics. These products are designed to address various challenges faced by dental professionals, such as improving treatment outcomes, ensuring infection prevention, and facilitating patient homecare. Young Innovations' products serve a diverse clientele, including dental practitioners, dental hygienists, and educational institutions, primarily in North America, while expanding into international markets.
The company's educational resources, such as the Young Education Suite, further enhance customer engagement by providing continuing education opportunities for dental professionals. Young Innovations operates on a business-to-business (B2B) model, generating revenue primarily through direct sales of dental products to dental practices, hospitals, and educational institutions. The total revenue for the most recent fiscal year was USD 106. 23 mn, with EBITDA recorded at USD 28.
49 mn. The company engages in transactions via established partnerships with distributors and wholesalers, allowing it to effectively reach a broad client base. Notable products include their range of infection control solutions and restorative instruments, marketed to dental professionals seeking high-quality, reliable tools for daily use. The company's revenue is reinforced by its commitment to customer service and support, solidifying its relationships within the dental community.
Looking ahead, Young Innovations plans to launch new products designed to address emerging needs within the dental industry, although specific release dates have yet to be announced. The company is targeting expansion into international markets to increase its global footprint. The recent funding of USD 314. 00 mn will be strategically utilized to support product development and market expansion initiatives, allowing the company to enhance its offerings and reach broader audiences.
Additionally, Maranon Capital exited its stake in Young Innovations, reflecting ongoing changes in investment dynamics.
Current Investors
Linden Capital Partners, Maranon Capital, Five Points Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Dental Products & Services, Medical Equipment Distributors, Medical Supplies
Website
www.ydnt.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Young Innovations, Inc. - financials
| Fiscal Year Ended | Dec 31, 2002 | Dec 31, 2003 | Dec 31, 2004 | Dec 31, 2005 | Dec 31, 2006 | Dec 31, 2007 | Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 04, 2012 | Dec 04, 2013 | Dec 04, 2014 | Dec 04, 2015 | Dec 04, 2016 | Oct 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 72,218,000 | 76,156,000 | 79,201,000 | 84,766,000 | 90,805,000 | 97,402,000 | 99,143,000 | 97,737,000 | 102,842,000 | 106,230,000 | 108,600,000 | - | - | - | - | - |
| % Revenue Growth (YoY) | - | 5.5% | 4.0% | 7.0% | 7.1% | 7.3% | 1.8% | (1.4%) | 5.2% | 3.3% | - | - | - | - | - | - |
| EBITDA (USD) | 21,534,000 | 23,894,000 | 24,297,000 | 26,252,000 | 27,207,000 | 24,921,000 | 23,766,000 | 25,553,000 | 27,190,000 | 28,485,000 | 29,400,000 | - | - | - | - | - |
| Operating Income (USD) | 18,998,000 | 21,269,000 | 21,131,000 | 23,825,000 | 23,483,000 | 20,760,000 | 19,753,000 | 21,538,000 | 23,020,000 | 24,360,000 | - | - | - | - | - | - |
| Operating Margin | 26.3% | 27.9% | 26.7% | 28.1% | 25.9% | 21.3% | 19.9% | 22.0% | 22.4% | 22.9% | - | - | - | - | - | - |
| % EBITDA Margin | 29.8% | 31.4% | 30.7% | 31.0% | 30.0% | 25.6% | 24.0% | 26.1% | 26.4% | 26.8% | 27.1% | - | - | - | - | - |
| NET Income (USD) | 11,411,000 | 13,201,000 | 13,934,000 | 15,338,000 | 14,779,000 | 12,933,000 | 12,181,000 | 13,481,000 | 14,937,000 | 16,453,000 | 17,200,000 | - | - | - | - | - |
| % Net Margin | 15.8% | 17.3% | 17.6% | 18.1% | 16.3% | 13.3% | 12.3% | 13.8% | 14.5% | 15.5% | 15.8% | - | - | - | - | - |
Young Innovations, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Salvin Dental Specialties, Inc. | - | ||||||||
| Add-on | Completed | Medical Purchasing Solutions, LLC | - | ||||||||
| Add-on | Completed | Preat Corporation | - | ||||||||
| N/A | Completed | 13705 Shoreline Court East, 2260 Wendt Street | - | ||||||||
| Add-on | Completed | Germiphene Corporation | - |
Displaying 1 - 5 of 15
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.